Companies / BioMarin Pharmaceutical Inc
BioMarin Pharmaceutical Inc
Financials · FY2025
Ownership
193.6M shares outstanding · as of Jul 28, 2026
Ownership
| Insiders | 0.52% | 1,015,600 |
| 10%+ / strategic | 14.30% | 27,673,970 |
| Institutions | 89.57% | 173,381,087 |
| Public float | 0.00% | 0 |
Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 17
View all →| Insider | % of shares | Shares |
|---|---|---|
Hardy AlexanderCEOChief Executive Officer · Director | 0.11% | 214,635 |
Meier Richard aDirector | 0.07% | 126,926 |
Mueller BrianEVP, Chief Financial Officer | 0.06% | 123,314 |
Guyer Charles GregEVP, Chief Technical Officer | 0.04% | 84,140 |
Davis George EricEVP, Chief Legal Officer | 0.04% | 78,560 |
Friberg Gregory REVP, Chief R&D Officer | 0.03% | 51,818 |
Hombach Robert J.Director | 0.03% | 49,360 |
Dere Willard HDirector | 0.02% | 46,440 |
Hubbard CristinEVP, Chief Commercial Officer | 0.02% | 42,472 |
Anderson Elizabeth MDirector | 0.02% | 41,940 |
Institutional holders 555
View all →| Holder | Value | % of shares |
|---|---|---|
| $1.17B | 10.56% | |
| $1.08B | 9.36% | |
| $866.04M | 7.53% | |
| $864.67M | 7.52% | |
| $447.57M | 3.89% | |
| $446.37M | 4.03% | |
| $429.35M | 3.97% | |
| $398.94M | 3.65% | |
| $215.81M | 1.97% | |
| $197.40M | 1.72% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | Davis George Eric Executive | Sell | Common Stock | $1.60M | -26K -26.45% | 72,453 0.04% of shares | medium |
| Mar 11, 2026 | Guyer Charles Greg Executive | Sell | Common Stock | $996.7K | -16K -17.09% | 79,953 0.04% of shares | medium |
| Mar 13, 2026 | Mueller Brian Executive | Other | Common Stock | $581.9K | -10K -8.53% | 106,691 0.06% of shares | low |
| Mar 13, 2026 | Guyer Charles Greg Executive | Other | Common Stock | $533.0K | -9K -11.39% | 70,843 0.04% of shares | low |
| Mar 16, 2026 | Davis George Eric Executive | Other | Common Stock | $419.9K | -7K -9.91% | 65,263 0.03% of shares | low |
| Feb 26, 2026 | Friberg Gregory R Executive | Sell | Common Stock | $381.9K | -6K -14.41% | 37,578 0.02% of shares | medium |
| Mar 17, 2026 | Hardy Alexander CEO | Other | Common Stock | $238.3K | -4K -1.94% | 214,635 0.11% of shares | low |
| May 7, 2026 | Friberg Gregory R Executive | Sell | Common Stock | $176.7K | -3K -5.95% | 51,818 0.03% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| BlackRock, Inc. | Passive13G/A | — |
| Vanguard Capital Management | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| BMRN | — | 09061G101 |